B. Andersson

发表

Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization.

N. Ueno, R. Champlin, L. Miller, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation.

K. Cleary, D. Couriel, R. Champlin, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Stem Cell Transplantation for CML Resistant to Tyrosine Kinase Inhibitors

E. Jabbour, P. Anderlini, P. Kebriaei, 2011 .

Human fetal thymus and bone marrow contain target cells for natural killer cells

M. Hansson, B. Andersson, R. Kiessling, 1981, European journal of immunology.

Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia

J. Palmblad, G. Gahrton, M. Björkholm, 2004, Cancer Chemotherapy and Pharmacology.

A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease.

E. Shpall, D. Couriel, A. Alousi, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes.

H. Kantarjian, E. Shpall, F. Ravandi, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome.

S. Parmar, E. Shpall, B. Valdez, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution

P. Thall, S. Parmar, J. Khoury, 2018, Oncotarget.

Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high‐dose cytosine arabinoside

H. Kantarjian, E. Freireich, M. Talpaz, 1988, Cancer.

Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.

E. Shpall, J. Cortes, F. Ravandi, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.

E. Shpall, Y. Nieto, U. Popat, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

PHASE II TRIAL OF GVHD PROPHYLAXIS WITH POSTTRANSPLANTATION CYCLOPHOSPHAMIDE FOLLOWING REDUCED-INTENSITY BUSULFAN/FLUDARABINE (BU/FLU) CONDITIONING FOR HEMATOLOGICAL MALIGNANCIES

E. Shpall, Y. Nieto, M. Qazilbash, 2016 .